Pharmaceutical Technology

SEPTEMBER 1, 2022

While nucleic acid amplification tests - a type of viral diagnostic test for a virus or bacterium that detects genetic materials rather than antigens or antibodies - can provide a shorter turnaround time, they come with challenges, ranging from their complex nature to the intensity of labour required in their creation.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

pharmaphorum

JUNE 16, 2022

The Medicines and Healthcare products Regulatory Agency’s (MHRA) gave a conditional approval to Idefirix – an enzyme derived from the bacterium Streptococcus pyogenes that breaks down immunoglobulin G (IgG) antibodies in the body – in 2020. The post Hansa gets NICE okay for Idefirix in kidney transplant patients appeared first on.

Antibody 52

Antibody Bacterium Clinical Trials Clinical Trials 52

XTalks

JULY 28, 2021

Compared to Vaxneuvance’s targeting of 15 different strains of the bacterium, Pfizer’s shot protects against 20. Both next-gen shots offer enhanced protection against bacteria that can cause pneumonia, blood infections and meningitis. This is seven more strains than its current winning vaccine Prevnar 13, which registered $5.95

FDA Approval 89

FDA Approval Vaccination Vaccine Immune Response 89

XTalks

JULY 25, 2023

Anthrax is a rare, yet severe disease caused by the bacterium B. The non-inferiority of Cyfendus to BioThrax was statistically determined in the clinical study results. Moreover, the clinical trials demonstrated that Cyfendus exhibited a favorable tolerability profile. What Is Anthrax? Additionally, at Day 64, 86.6

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

XTalks

JANUARY 20, 2021

To test their hypothesis in the lab, the researchers infected mice with a stomach bacterium and fed them a protein found in egg white called ovalbumin at the same time (this protein is commonly used as a typical model food antigen in experiments). The antihistamine treatment is currently being evaluated in larger clinical trials.

Immune Response 52

Immune Response Research Allergies Protein 52

The Pharma Data

MARCH 21, 2022

Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat glioblastoma, a brain cancer. That was surprising,” she said.

Bacterium 52

Bacterium Scientist Clinical Trials Clinical Trials 52

The Pharma Data

JUNE 2, 2022

” In the adult phase I/II clinical trials, AFX3772 was well tolerated in participants and demonstrated good immune responses compared to the current standard of care. Phase I/II clinical trials to assess the use of the vaccine in paediatrics are planned to begin later this year. About Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

MAY 31, 2022

In the adult phase I/II clinical trials, AFX3772 was well tolerated in participants and demonstrated good immune responses compared to the current standard of care. Phase I/II clinical trials to assess the use of the vaccine in paediatrics are planned to begin later this year. Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

pharmaphorum

JULY 14, 2021

The shot also includes two “conserved” pneumococcal proteins – antigens that seem always to be present in the bacterium regardless of its serotype, so could potentially provide protection against an even broader range.

Immune Response 52

Immune Response Vaccination Vaccine Protein 52

XTalks

NOVEMBER 10, 2020

Originally published on July 15, 2020: Quebec-based biotechnology company Medicago has developed a plant-derived vaccine for COVID-19 that is now undergoing early-stage clinical trials. The Phase I trials will evaluate the safety of the plant-based vaccine in a cohort of 180 healthy men and women between the ages of 18 and 55.

Vaccination 52

Vaccination Vaccine Trials Immune Response 52

XTalks

AUGUST 2, 2023

Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. At present, the company has approximately 45 new drugs in Phase II or Phase III clinical trials, or awaiting approval from regulatory authorities in the US, Europe or Japan. billion ($3.65

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 24, 2020

As of November, the WHO has discouraged the use of the drug as the agency’s review of data from four different clinical trials yielded no worthy effect on mortality, need for mechanical ventilation, time to clinical improvement or any other important patient outcomes. CRISPR Therapeutics. Immunotherapies.

Life Science 111

Life Science Vaccination Vaccine Gene 111